Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19

doi:10.3748/wjg.v28.i37.5444

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4768)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

202

WORD

HTML

2181

Figures (1-4)

344

Tables (1-5)

296

Sum=3069

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

360

Download

1339

Sum=1699

Oct 7, 2022 (publication date) through Sep 18, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Oct 7, 2022; 28(37): 5444-5456
Published online Oct 7, 2022. doi: 10.3748/wjg.v28.i37.5444

Table 2 Diagnostic yield of the LFN-COVID-19 index in patients with metabolic associated fatty liver disease

Diagnostic yield
Sensitivity	0.787 (0.643-0.893)
Specificity	0.638 (0.563-0.709)
Positive predictive value, %	0.360 (0.273-0.468)
Negative predictive value, %	0.910 (0.855-0.960)
+ Likelihood ratio	2.18 (1.70-2.80)
- Likelihood ratio	0.33 (0.20-0.60)
AUROC	0.770 (0.709-0.823), P < 0.0001
Youden index	0.4257

AUROC: Area under the receiver operating characteristic.

Citation: Macías-Rodríguez RU, Solís-Ortega AA, Ornelas-Arroyo VJ, Ruiz-Margáin A, González-Huezo MS, Urdiales-Morán NA, Román-Calleja BM, Mayorquín-Aguilar JM, González-Regueiro JA, Campos-Murguía A, Toledo-Coronado IV, Chapa-Ibargüengoitia M, Valencia-Peña B, Martínez-Cabrera CF, Flores-García NC. Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19. World J Gastroenterol 2022; 28(37): 5444-5456
URL: https://www.wjgnet.com/1007-9327/full/v28/i37/5444.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i37.5444